logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

CGEN
Compugen Ltd.
2.13
2 x 1.56
2 x 2.72
bid
ask
-
0.01
0.47%
2 @ 04:01 AM
2.06 -0.07 (3.29%)
Ytd39.22%
1y23.12%
2.10
day range
2.18
1.30
52 week range
3.24
Open2.17Prev Close2.14Low2.10High2.18Mkt Cap201.47M
Vol172.31KAvg Vol498.07KEPS0.38P/E5.61Forward P/E-13.82
Beta2.65Short Ratio6.42Inst. Own14.97%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg2.48200-d Avg1.991yr Est4.00

CGEN News

benzinga.com
Compugen Presents Trial-In-Progress Poster On MAIA-Ovarian Adaptive Platform Trial Of COM701, Potent

Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer

benzinga.com
Compugen To Present Trial-In-Progress Poster On MAIA-Ovarian Phase 1 Study Of COM701, Anti-PVRIG Ant

Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer

Compugen Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Compugen Q1 2026 Earnings Call: Complete Transcript